Lyell Immunopharma (LYEL) Stock Chart & Stock Price History $11.40 +0.08 (+0.72%) As of 12:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lyell Immunopharma Stock Price Performance The Lyell Immunopharma (LYEL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 61.99%, with a year-to-date return of -10.92%. In the past month, the stock has increased 22.08%, reflecting recent market activity. As of the latest close, Lyell Immunopharma traded at $11.32 with a market cap of $175.01 million and volume of 49,831 shares. Receive LYEL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lyell Immunopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.47%1 Month Performance+22.08%3 Month Performance+33.20%Year-To-Date Performance-10.92%1 Year Performance-61.99% LYEL Stock Chart for Friday, August, 8, 2025 LYEL Chart by TradingView Lyell Immunopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$11.08$11.32+2.17%$11.74$10.8749,831 shs$175.01 million08/06/2025$11.43$11.08-3.06%$11.76$10.9321,942 shs$171.30 million08/05/2025$11.37$11.43+0.53%$12.08$11.4328,288 shs$176.71 million08/04/2025$11.02$11.37+3.18%$11.70$10.9432,031 shs$163.18 million08/01/2025$11.81$11.02-6.69%$11.67$11.0219,787 shs$163.18 million07/31/2025$12.44$11.81-5.06%$12.53$11.5540,444 shs$174.91 million07/30/2025$12.87$12.44-3.34%$13.13$12.2441,334 shs$184.24 million07/29/2025$13.73$12.87-6.26%$14.01$12.68110,920 shs$190.58 million07/28/2025$12.42$13.73+10.55%$14.18$12.59255,147 shs$203.34 million07/25/2025$10.41$12.42+19.31%$13.04$11.11461,647 shs$183.94 million Get the Latest News and Ratings for LYEL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lyell Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$10.99$10.41-5.28%$11.17$10.2634,970 shs$154.17 million07/23/2025$10.28$10.99+6.91%$11.11$10.0443,182 shs$162.74 million07/22/2025$9.49$10.28+8.32%$10.35$9.5650,380 shs$152.25 million07/21/2025$9.24$9.49+2.71%$9.81$9.3128,180 shs$140.55 million07/18/2025$9.52$9.24-2.94%$9.75$9.2424,175 shs$136.84 million07/17/2025$9.53$9.52-0.10%$9.83$9.1125,812 shs$140.97 million07/16/2025$9.10$9.53+4.73%$9.64$9.1629,573 shs$141.14 million07/15/2025$9.67$9.10-5.89%$9.83$9.0236,808 shs$134.75 million07/14/2025$9.75$9.67-0.82%$9.83$9.5819,243 shs$143.19 million07/11/2025$9.77$9.75-0.20%$9.95$9.6123,433 shs$144.38 million07/10/2025$10.21$9.77-4.31%$10.41$9.6339,054 shs$144.69 million07/09/2025$9.34$10.21+9.31%$10.37$9.3571,925 shs$151.21 million07/08/2025$9.15$9.34+2.08%$9.44$9.1545,396 shs$138.33 million07/07/2025$9.42$9.15-2.81%$9.64$9.1167,590 shs$143.49 million Related Companies CRON Stock Price Chart GHRS Stock Price Chart UPB Stock Price Chart NAGE Stock Price Chart DNA Stock Price Chart IMA Stock Price Chart VIR Stock Price Chart QURE Stock Price Chart TNGX Stock Price Chart AMLX Stock Price Chart Receive LYEL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lyell Immunopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LYEL) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyell Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyell Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
